Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
FirstWord Pharma,
HOUSTON, Oct. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage…
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
Biospace,
HOUSTON, Oct. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage…
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
Ticker Tech,
Initial information sharing agreement signed to further research into the anti-viral potential of WP1122 HOUSTON, Oct.
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
Finanzen.ch,
HOUSTON, Oct. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage…
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
ProfitQuotes.com,
Initial information sharing agreement signed to further research into the anti-viral potential of WP1122 HOUSTON, Oct.
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
Ariva,
PR Newswire HOUSTON, Oct. 29, 2020 HOUSTON, Oct. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin…
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
MarketScreener,
HOUSTON, Oct. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage…
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
WFMZ-TV 69,
HOUSTON, Oct. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage…
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
Benzinga,
HOUSTON, Oct. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (NASDAQ:) ("Moleculin" or the "Company"), a clinical stage…
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
Morning Star,
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19 Initial information sharing agreement signed…
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
PR Newswire,
Initial information sharing agreement signed to further research into the anti-viral potential of WP1122 HOUSTON, Oct.
MOLECULIN BIOTECH : Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target
MarketScreener,
HOUSTON - Moleculin Biotech, Inc., (Nasdaq: MBRX) ('Moleculin' or the 'Company'), a clinical stage pharmaceutical company with…
Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target
VB Profiles,
Research findings provide further scientific support for the mechanism of action of Moleculin's prodrug WP1122 HOUSTON, July 29…
Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target
Ticker Tech,
Research findings provide further scientific support for the mechanism of action of Moleculin's prodrug WP1122 HOUSTON, July 29…
Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target
Finanzen,
, /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical…
Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target
Ariva,
Moleculin Biotech-Aktie dauerhaft für 0 Euro handeln! Jetzt auf Smartbroker.de PR Newswire HOUSTON, July 29, 2020 HOUSTON, July…
Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target
WFMZ-TV 69,
/PRNewswire/ --., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio…
Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target
Morning Star,
Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target Research findings provide…
Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target
Benzinga,
/PRNewswire/ -- Moleculin Biotech, Inc., (NASDAQ:) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with…
Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target
PR Newswire,
Research findings provide further scientific support for the mechanism of action of Moleculin's prodrug WP1122 HOUSTON, July 29…
Additional Independent Research Further Supports Glucose Metabolism As Important COVID-19 Target
The Street,
Research findings provide further scientific support for the mechanism of action of Moleculin's prodrug WP1122 HOUSTON, July 29…
Vaccine developments in China include IND acceptance for Fosun, Phase II start for Chongqing Zhifei
BioCentury,
BioCentury is providing this content for free given the urgent need for information about the coronavirus crisis.
News story from Finanz Nachrichten on Monday 22 June 2020
Finanz Nachrichten,
Korrektur: Lizenzgeber von WPD Pharmaceuticals meldet Bestätigung für In-vitro-Analyse von WP1122
Wall Street Online Denmark,
Vancouver (British Columbia), 22. Juni 2020. WPD Pharmaceuticals Inc. (CSE: WBIO, FWB: 8SV1) („WPD“ oder das „Unternehmen“)…
Korrektur: Lizenzgeber von WPD Pharmaceuticals meldet Bestätigung für In-vitro-Analyse von WP1122
Ariva,
WPD Pharmaceuticals-Aktie dauerhaft für 0 Euro handeln! Jetzt auf Smartbroker.de Vancouver (British Columbia), 22.
WPD Pharmaceuticals Licensor Announces Confirmatory in Vitro Analysis of WP1122
Spoke,
(GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “ Company ” or “ WPD ”), a clinical stage…
WPD Pharmaceuticals Licensor Announces Confirmatory in Vitro Analysis of WP1122
Biz Wire Express,
(GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Companyâ€? or “WPDâ€?), a clinical stage…
WPD Pharmaceuticals Licensor Announces Confirmatory in Vitro Analysis of WP1122
Jotup,
, Moleculin announced results from the initial preclinical assessment of the potential for WP1122 to address COVID-19.
WPD Pharmaceuticals Licensor Announces Confirmatory in Vitro Analysis of WP1122
Digital Journal,
(GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “ Company ” or “ WPD ”), a clinical stage…
WPD PHARMACEUTICALS : Licensor Announces Confirmatory in Vitro Analysis of WP1122
MarketScreener,
(GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “ Company ” or “ WPD ”), a clinical stage…
WPD Pharmaceuticals Licensor Announces Confirmatory in Vitro Analysis of WP1122
EIN Newsdesk,
(GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical…
WPD Pharmaceuticals Licensor Announces Confirmatory in Vitro Analysis of WP1122
Yahoo! Finance USA,
(GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE:WBIO)( 8SV1.F ) (the “ Company ” or “ WPD ”), a clinical stage pharmaceutical…
WPD Pharmaceuticals Licensor Announces Confirmatory in Vitro Analysis of WP1122
Benzinga,
(GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE:)(FSE: 8SV1) (the " Company " or " WPD "), a clinical stage pharmaceutical…
WPD Pharmaceuticals Licensor Announces Confirmatory in Vitro Analysis of WP1122
EINPresswire,
(GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “ Company ” or “ WPD ”), a clinical stage…
WPD Pharmaceuticals Licensor Announces Confirmatory in Vitro Analysis of WP1122
Wall Street Online Denmark,
(GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical…
WPD Pharmaceuticals Licensor Announces Confirmatory in Vitro Analysis of WP1122
GlobeNewswire,
(GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “ Company ” or “ WPD ”), a clinical stage…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
Biospace,
HOUSTON, June 16, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
gurufocus,
Receives feedback from FDA on Pre-IND meeting Receives feedback from FDA on Pre-IND meeting PR Newswire HOUSTON, June 16, 2020…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
ProfitQuotes.com,
Receives feedback from FDA on Pre-IND meeting HOUSTON, June 16, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: ) ("Molecu…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
PharmiWeb,
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
Finanzen,
, /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
Ariva,
Moleculin Biotech-Aktie dauerhaft für 0 Euro handeln! Jetzt auf Smartbroker.de PR Newswire HOUSTON, June 16, 2020 HOUSTON, June…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
Crwe World,
Receives feedback from FDA on Pre-IND meeting HOUSTON, June 16, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Mo…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
Stockwatch,
Receives feedback from FDA on Pre-IND meeting HOUSTON, June 16, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Mo…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
Ticker Tech,
Receives feedback from FDA on Pre-IND meeting HOUSTON, June 16, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX ) ("M…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
MarketScreener,
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
Killeen Daily Herald,
/PRNewswire/ --., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
WFMZ-TV 69,
/PRNewswire/ --., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio…
Moleculin Announces Confirmatory In Vitro Analysis Of WP1122
The Street,
Receives feedback from FDA on Pre-IND meeting HOUSTON, June 16, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Mo…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
Finanzen.ch,
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
Morning Star,
Moleculin Announces Confirmatory In Vitro Analysis of WP1122 Receives feedback from FDA on Pre-IND meeting PR Newswire HOUSTON…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
Benzinga,
/PRNewswire/ -- Moleculin Biotech, Inc., (NASDAQ:) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
KPVI,
/PRNewswire/ --., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio…
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
PR Newswire,
Receives feedback from FDA on Pre-IND meeting HOUSTON, June 16, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX ) ("M…
Schwergewichtige Aminosäuren vs Virus
Laborjournal,
) Eigentlich wollte Christian Münchs Gruppe eine Proteomik-Technik verbessern, nun könnte die neue mePROD-Methode sogar SARS-2-Wi…
Вчені заявили про ефективність відомих ліків проти COVID-19
Obozrevatel,
Препарат рибавірин здатний сповільнювати й навіть зупиняти розмноження коронавірусу SARS-CoV-2 в організмі людини, припустили вче…
Ученые заявили об эффективности известного лекарства против COVID-19
Obozrevatel,
Препарат рибавирин способен замедлять и даже останавливать размножение коронавируса SARS-CoV-2 в организме человека, предположили…
German researchers identify potential cellular targets for treating virus that causes Covid
The Pioneer,
Offering hope for treatment of the coronavirus infection that has caused havoc across the world, a team of German researchers…
German Researchers Discover Potential Cell Targets For Treating COVID-19
Odisha TV,
London: A team of German researchers has identified potential cellular targets for treating SARS-CoV-2, the virus that causes…
German researchers discover potential cell targets for treating COVID-19
New Kerala,
A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital in Germany tested a series of…
German researchers discover potential cell targets for treating COVID-19
Daijiworld.com,
London, May 15 (IANS): A team of German researchers has identified potential cellular targets for treating SARS-CoV-2, the…
German researchers discover potential cell targets for treating COVID-19
India4u,
London, May 15 : A team of German researchers has identified potential cellular targets for treating SARS-CoV-2, the virus that…
German Researchers Discover Potential Cell Targets for Treating Covid-19
News 18,
Image for representation (Reuters) According to the researchers, these results now enable the search for an active substance to…
Good News: German researchers make breakthrough in COVID-19 battle
Dailyhunt,
Using a technique developed at the Institute for Biochemistry II at Goethe University, researchers from both institutions were…
German researchers discover potential cell targets for treating COVID-19
India Post,
LONDON: A team of German researchers has identified potential cellular targets for treating SARS-CoV-2, the virus that causes…
Good News: German researchers make breakthrough in COVID-19 battle
News24,
London: Scientists all over the world are working hard to come up with a vaccine for the COVID-19 virus which can defeat the…
German researchers discover potential cell targets for treating COVID-19
Outlook India,
London, May 15 (IANS) A team of German researchers has identified potential cellular targets for treating SARS-CoV-2, the virus…
German researchers discover potential cell targets for treating COVID-19
ProKerala,
London, May 15 : A team of German researchers has identified potential cellular targets for treating SARS-CoV-2, the virus that…
Unique MS Method Could Narrow Down Search for COVID-19 Drug Treatment
Laboratory Equipment ,
A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human…
German researchers discover potential cell targets for treating COVID-19
CanIndia,
London, May 15 (IANS) A team of German researchers has identified potential cellular targets for treating SARS-CoV-2, the virus…
Researchers observe how SARS-CoV-2 changes human cells after infection, revealing drug targets
Drug Target Review,
Using mass spectrometry, researchers have shown how human cells are changed by infection from SARS-CoV-2, allowing the team to…
German researchers discover potential cell targets for treating COVID-19
SocialNews.XYZ,
London, May 15 (SocialNews.XYZ) A team of German researchers has identified potential cellular targets for treating SARS-CoV-2…
Ansatzpunkte für COVID-19-Therapie
GIT Laborportal,
Mehrere Wirkstoffe stoppen SARS-CoV-2-Virus im Zellkultur-Modell Wie das SARS-CoV-2-Virus, der Erreger von COVID-19…
Ученые нашли лекарство от коронавируса
РИА Новости,
МОСКВА, 14 мая – РИА Новости. Противовирусный препарат рибавирин, применяемый против гепатита и других инфекций, может быть эффек…
Researchers discover potential targets for COVID-19 therapy
Science Daily,
Researchers were able to observe how human cells change upon infection with SARS-CoV-2, the virus causing COVID-19 in people.
Scientists Have a Promising New Idea to Defeat the Coronavirus
Futurism,
In order to find new treatments for COVID-19, scientists are probing how the coronavirus alters human cells when it infects and…
Sars-CoV-2: Neue Ansatzstellen für Gegenmittel
FOCUS Online,
Deutsche Forscher haben erstmals entschlüsselt, wie und wo das Coronavirus in die Proteinproduktion unserer Zellen eingreift …
Potential cell targets for treating COVID-19 discovered by scientists in Germany
FOX News,
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
Frankfurt researchers discover potential targets for COVID-19 therapy
7th Space Family Portal,
.newsblock { width: 200px; height:200px; float:right; padding-left:15px; padding-right:15px; } A team of biochemists and…
Potential targets discovered for COVID-19 therapy
The Medical News,
A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human…
Sars-CoV-2: Neue Ansatzstellen für Gegenmittel - wissenschaft.de
wissenschaft.de,
Bisher gibt es gegen Sars-CoV-2 kein wirksames Gegenmittel, auch wenn einige Wirkstoff-Kandidaten den Verlauf von Covid-19…
Researchers discover potential targets for COVID-19 therapy
Phys.org,
A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human…
Frankfurter Forscher entdecken Ansatzpunkte für COVID-19-Therapie
Innovations Report,
14.05.2020 Zellkultur-Modell: Mehrere Wirkstoffe stoppen SARS-CoV-2-Virus Wie das SARS-CoV-2-Virus, der Erreger von COVID-19…
Frankfurter Forscher entdecken Ansatzpunkte für COVID-19-Therapie
Jura Forum,
Zellkultur-Modell: Mehrere Wirkstoffe stoppen SARS-CoV-2-Virus Wie das SARS-CoV-2-Virus, der Erreger von COVID-19, menschliche…
Studie aus Frankfurt: Zellkultur-Versuche zeigen Therapie-Ansätze für Covid-19
Frankfurter Allgemeine,
Forscher der Universität Frankfurt haben im Labor untersucht, wie das neue Coronavirus Körperzellen für seine Zwecke…
Frankfurt researchers discover potential targets for COVID-19 therapy
Informationsdienst Wissenschaft,
11:00 Cell culture model: several compounds stop SARS-CoV-2 virus A team of biochemists and virologists at Goethe University…
Frankfurter Forscher entdecken Ansatzpunkte für COVID-19-Therapie
Informationsdienst Wissenschaft,
11:00 Zellkultur-Modell: Mehrere Wirkstoffe stoppen SARS-CoV-2-Virus Wie das SARS-CoV-2-Virus, der Erreger von COVID-19…
Team of Biochemists and Virologists Discover Potential Targets for COVID-19 Therapy
Scitech Daily,
Cell culture model: several compounds stop SARS-CoV-2 virus. A team of biochemists and virologists at Goethe University and the…
Frankfurt researchers discover potential targets for COVID-19 therapy
EurekAlert!,
A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human…
Исследователи объявили о новом лекарстве, противостоящем коронавирусу
РИА Новости,
МОСКВА, 14 мая/ Радио Sputnik. Противовирусный препарат рибавирин, который применяют против гепатита и других инфекций, может ста…
Frankfurter Forscher entdecken Ansatzpunkte für COVID-19-Therapie
AlphaGalileo,
Zellkultur-Modell: Mehrere Wirkstoffe stoppen SARS-CoV-2-Virus Wie das SARS-CoV-2-Virus, der Erreger von COVID-19, menschliche…
Frankfurt researchers discover potential targets for COVID-19 therapy
AlphaGalileo,
Cell culture model: several compounds stop SARS-CoV-2 virus A team of biochemists and virologists at Goethe University and the…